Hepatic fibrosis underlies most types of chronic liver diseases and is characterized by excessive deposition of extracellular matrix (ECM), altered liver architecture, and impaired hepatocyte proliferation; however, the fibrotic liver can still regenerate after partial hepatectomy (PH). Therefore, the present study was aimed at addressing whether a PH-induced regeneration normalizes ECM turnover and the possible involvement of hepatic stellate cells (HSC) during resolution of a pre-established fibrosis. Male Wistar rats were rendered fibrotic by intraperitoneal administration of swine serum for 9 weeks and subjected afterwards to 70% PH or sham-operation. Histological and morphometric analyses were performed, and parameters indicative of cell proliferation, collagen synthesis and degradation, and activation of HSC were determined. Liver collagen content was reduced to 75% after PH in cirrhotic rats when compared with sham-operated cirrhotic rats. The regenerating fibrotic liver oxidized actively free proline and had diminished transcripts for α-1 (I) collagen mRNA, resulting in decreased collagen synthesis. PH also increased collagenase activity, accounted for by higher amounts of pro-MMP-9, MMP-2, and MMP-13, which largely coincided with a lower expression of TIMP-1 and TIMP-2. Therefore, an early decreased collagen synthesis, mild ECM degradation, and active liver regeneration were followed by higher collagenolysis and limited deposition of ECM, probably associated with increased mitochondrial activity. Activated HSC readily increased during liver fibrosis and remained activated after liver regeneration, even during fibrosis resolution. In conclusion, stimulation of liver regeneration through PH restores the balance in ECM synthesis/degradation, leading to ECM remodeling and to an almost complete resolution of liver fibrosis. As a response to the regenerative stimulus, activated HSC seem to play a controlling role on ECM remodeling during experimental cirrhosis in rats. Therefore, pharmacological approaches for the resolution of liver fibrosis by blocking HSC activation should also evaluate possible effects on liver cell proliferation.
Get full access to this article
View all access options for this article.
References
1.
Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol11:S37–S43, 2001.
2.
Shuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as modulator of hepatic fibrogenesis. Semin Liver Dis21:351–372, 2001.
3.
Martínez-Hernández A, Sebastían-Amenta P. The extracellular matrix in hepatic regeneration. FASEB J9:1401–1410, 1995.
4.
Rojkind M, Greenwel P. Animal models of liver fibrosis. Adv Vet Sci Comp Med37:333–335, 1993.
5.
Chanda S, Mangipudy RS, Warbritton A, Bucci TJ, Mehendale HM. Stimulated hepatic tissue repair underlies heteroprotection by thioace-tamide against acetaminophen-induced lethality. Hepatology21:477–486, 1995.
6.
Rojkind M, Greenwel P. Pathophysiology of liver fibrosis. Oxford Textbook of Clinical Hepatology. Edited by McIntyre N, Benhamou J-P, Bircher J, Rizzeto M and Rodes J. New York, Oxford Medical Publication, p. 375–380, 1991.
7.
Friedman SL. Molecular Regulation of hepatic fibrosis, and integrated cellular response to tissue injury. Minireview. J Biol Chem275:2247–2250, 2000.
8.
Pinzani M. Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol42:S22–S36, 2005.
9.
Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med350:1646–1654, 2004.
10.
Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis5:315–334, 2001.
11.
Arthur MJP. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol279:G245–G249, 2000.
12.
Bataller R, Brenner DA. Liver fibrosis. J Clin Invest115:209–218, 2005.
13.
Bruck R, Genina O, Aeed H, Alexiev R, Nagler A, Avni Y, Pines M. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology33:379–386, 2001.
14.
Kato A, Bamba H, Shinohara M, Yamauchi A, Ota S, Kawamoto C, Yoshida Y. Relationship between expression of cyclin D1 and impaired liver regeneration observed in fibrotic or cirrhotic rats. J Gastroenterol Hepatol20:1198–1205, 2005.
15.
Andiran F, Kilinc K, Renda N, Ayhan A, Tanyel FC. Lipid peroxidation and extracellular matrix in normal and cirrhotic rat livers following 70% hepatectomy. Hepatogastroenterology50:805–808, 2003.
16.
Kanta J, Chlumská A. Regenerative ability of hepatocytes is inhibited in early stages of liver fibrosis. Physiol Res40:453–458, 1991.
17.
Rozga J, Foss A, Alumets J, Ahren B, Jeppsson B, Bengmark S. Liver cirrhosis in rats: regeneration and assessment of the role of phenobarbital. J Surg Res51:329–335, 1991.
18.
Hashimoto M, Watanabe G. Functional restoration of cirrhotic liver after partial hepatectomy in the rat. Hepatogastroenterology52:897–902, 2005.
19.
Assy N, Hussein O, Khalil A, Luder A, Szvalb S, Paizi M, Spira G. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci52:1187–1193, 2007.
20.
Ozawa S, Uchiyama K, Nakamori M, Ueda K, Iwahashi M, Ueno H, Muragaki Y, Ooshima A, Yamaue H. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy. Surgery139:563–573, 2006.
21.
Oe H, Kaido T, Furuyama H, Mori A, Imamura M. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats. Hepatogastroenterology51:1641–1647, 2004.
22.
Mohammed FF, Khokha R. Thinking outside the cell: proteases regulate hepatocyte division. Trends Cell Biol15:555–563, 2005.
23.
Roselli HT, Su M, Washington K, Kerins DM, Vaughan DE, Russell WE. Liver regeneration is transiently impaired in urokinase-deficient mice. Am J Physiol275:G1472–G1479, 1998.
24.
Issa R, Zhou X, Trim N, Millward-Sadler H, Krane S, Benyon C, Iredale J. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J17:47–49, 2003.
25.
Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, Khokha, R. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology41:857–867, 2005.
26.
Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C, Marumo F. Phenotypic modulation in lypocytes in experimental liver fibrosis. J Pathol164:273–278, 1991.
27.
Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology122:1525–1528, 2002.
28.
Rudin CM, Thompson CB. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med40:267–281, 1997.
29.
Paronetto F, Popper C. Chronic liver injury induced by immunologic reactions. Cirrhosis following immunization with heterologous sera. Am J Pathol49:1087–1101, 1966.
30.
Montfort I, Perez-Tamayo R, Alvizouri AM, Tello E. Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver. Virchows Arch B Cell Pathol Mol Pathol59:281–289, 1990.
31.
Zhao G, Nakano K, Chijiiwa K, Ueda J, Tanaka M. Inhibited activities in CCAAT/enhancer-binding protein, activating protein-1 and cyclins after hepatectomy in rats with thioacetamide-induced liver cirrhosis. Biochem Biophys Res Commun292: 474–481, 2002.
32.
Miyamoto M, Manabe N, Uchio K, Kuramitsu K, Tamura D. Characteristics of lectin staining patterns assessed by a modified sensitive thermo-method in rat livers with heterologous serum-induced fibrosis. J Vet Med Sci60:953–960, 1998.
33.
Higgins GM, Anderson RM. Experimental pathology of the liver: the restoration of liver of white rat following surgical removal. Arch Pathol12:186–202, 1931.
34.
Fujiwara K, Ogata I, Ohta Y, Hayashi S, Mishiro S, Takatsuki K, Sato Y, Yamada S, Hirata K, Oka H. Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver. Hepatology8:804–807, 1988.
35.
Hernández-Muñoz R, Díaz-Muñoz M, Suárez-Cuenca JA, Trejo-Solís C, López V, Sánchez-Sevilla L, Yañez L, Chagoya de Sánchez V. Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology34:677–687, 2001.
36.
Rojkind M, González E. An improved method for determining specific radioactivities of proline-14C and hydroxyproline-14C in collagen and non-collagenous proteins. Anal Biochem57:1–7, 1974.
37.
Hernández-Muñoz R, Díaz-Muñoz M, Chagoya de Sánchez V. Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology12:242–248, 1990.
38.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem162:156–159, 1987.
39.
Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels of TGFb, fibronectin, and collagen. Am J Physiol262: H1860–H1866, 1992.
40.
Knittel H, Mehde M, Grundmann B, Scharf JG, Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol113:443–453, 2000.
41.
Laemmli UK. Cleavage of structural proteins during the assembly of the headbacteriophage T4. Nature227:680–685, 1970.
42.
Michalopoulos GK, DeFrances M. Liver regeneration. Adv Biochem Engin Biotechnol93:101–134, 2005.
43.
Rojkind M, Rojkind MH, Cordero-Hernandez J. In vivo collagen synthesis and deposition in fibrotic and regenerating rat livers. Coll Relat Res3:335–347, 1983.
44.
Hernández-Muñoz R, Díaz-Muñoz M, Chagoya de Sánchez V. Possible role of cell redox state on collagen metabolism in carbon tetrachloride-induced cirrhosis as evidenced by adenosine administration to rats. Biochim Biophys Acta1200:93–99, 1994.
45.
Hernández-Muñoz R, Sánchez-Sevilla L, Martínez-Gómez A, Dent MA. Changes in mitochondrial adenine nucleotides and in permeability transition in two models of rat liver regeneration. Hepatology37:842–851, 2003.
Siegmund SV, Dooley S, Brenner DA. Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis23:264–274, 2005.
48.
Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol200:504–515, 2003.
49.
Zheng WD, Zhang LJ, Shi MN, Chen ZX, Chen YX, Huang YH, Wang XZ. Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10. World J Gastroenterol11:1753–1758, 2005.
50.
Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem267:4583–4591, 1992.
51.
Serandour AL, Loyer P, Garnier D, Courselaud B, Theret N, Glaise D, Guguen-Guillouzo C, Corlu A. TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology41:478–486, 2005.
52.
Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology26:896–904, 1997.
53.
Morimoto T, Isselhard W. Absence of mitochondrial enhancement in the remnant liver after partial hepatectomy in cirrhotic rats. Res Exp Med (Berl)192:89–97, 1992.
54.
Chijiiwa K, Nakano K, Kameoka N, Nagai E, Tanaka M. Proliferating cell nuclear antigen, plasma fibronectin, and liver regeneration rate after seventy percent hepatectomy in normal and cirrhotic rats. Surgery116: 544–549, 1994.
55.
Mitsue S, Hamanoue M, Tanabe G, Ogura Y, Yoshidome S, Aikou T, Nakamura T. Expression of HGF and TGF-β1 mRNA after partial hepatectomy in rats with liver cirrhosis. Surg Today25:237–243, 1995.
56.
Masson S, Scotté M, François A, Coeffier M, Provot F, Hiron M, Ténière P, Fallu J, Salier JP, Daveau M. Changes in growth factor in cytokine mRNA levels after hepatectomy in rat with CCl4-induced cirrhosis. Am J Physiol277:G838–G846, 1999.
57.
Kaido T, Yoshikawa A, Seto S, Yamaoka S, Sato M, Ishii T, Imamura M. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats. Hepatology28:756–760, 1998.
58.
Oe H, Kaido T, Furuyama H, Mori A, Imamura M. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats. Hepatogastroenterology51:1641–1647, 2004.
59.
Ozawa S, Uchiyama K, Nakamori M, Ueda K, Iwahashi M, Ueno H, Muragaki Y, Ooshima A, Yamaue H. Combination gene therapy of HGF and truncated type II TGF-β receptor for rat liver cirrhosis after partial hepatectomy. Surgery139:563–573, 2006.
60.
Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol200:504–515, 2003.
61.
Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, Haslett C, Simpson KJ, Sethi T. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A103:5060–5065, 2006.
62.
Mabuchi A, Mullaney I, Sheard PW, Hessian PA, Mallard BL, Tawadrous MN, Zimmermann A, Senoo H, Wheatley AM. Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat. J Hepatol40:910–916, 2004.
63.
Aguilar-Delfin I, Lopez-Barrera F, Hernandez-Munoz R. Selective enhancement of lipid peroxidation in plasma membrane in two experimental models of liver regeneration: partial hepatectomy and acute CC14 administration. Hepatology24:657–662, 1996.
64.
Trejo-Solis C, Chagoya de Sanchez V, Aranda-Fraustro A, Sanchez-Sevilla L, Gomez-Ruiz C, Hernandez-Munoz R. Inhibitory effect of vitamin e administration on the progression of liver regeneration induced by partial hepatectomy in rats. Lab Invest83:1669–1679, 2003.
65.
Vollmar B, Siegmund S, Richter S, Menger MD. Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis. J Pathol189:85–91, 1999.
